Partial table of contents:
OVERVIEW OF PHARMACODYNAMICS.
Basic Pharmacodynamic Concepts and Models (R. Wills).
Factors Influencing Variability in Kinetics and Dynamics (P.
Narang& R. Li).
General Perspectives on the Role of Metabolite in
Pharmacokineticsand Pharmacodynamics (R. Seifert).
Regulatory Perspective: The Role of Pharmacokinetics
andPharmacodynamics (L. Lesko & R. Williams).
APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS.
Theoretical Models for Developing Anxiolytics (P. Nickell &
T.Uhde).
Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J.
Sramek& G. Simpson).
Antihypertensive Drugs (L. Prisant & A. Carr).
Pharmacodynamics of Antineoplastic Agents (G. Rosner &
M.Ratain).
Virology and Antiviral Drug Development (M. Amantea, et al.).
FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM
MOLECULARAPPROACHES.
Muscarinic Receptors: Pharmacological Subtypes, Structure,
Functionand Regulation (L. Mei, et al.).
Serotonin Receptor Subtypes (D. Pritchett).
Index.
Neal R. Cutler is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley. John J. Sramek is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley.
 |
Ask a Question About this Product More... |
|
